Article title: Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma.
Author: Wang H, Su X, Yang M, Chen T, Hou J, Li N, Cao X.
Journal: OncoImmunology.
DOI: https://doi.org/10.1080/2162402X.2015.1031440
In the published version of , the data for PBS group in STAT3 staining panel and the PBS, NC and miR-197 groups in p-STAT3 staining panel were inadevertently presented with incorrect images during figure assembly for manuscript submission. The corrected is shown as below. The figure legend is correct as published and is also shown for reference. The data were not manipulated in any way, the errors have no bearings on the interpretation of the results, nor do they influence the conclusions of the work.
Figure 5. miR-197 suppresses HCC growth in vivo
![Figure 5. miR-197 suppresses HCC growth in vivo](/cms/asset/afd420ac-d579-4b15-b1f7-04e401136a8c/koni_a_1703612_f0001_oc.jpg)
We apologize for any inconvenience it may have caused.